| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |